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and a neurohumoral mechanism that lead e.g. to an 
increase in heart rate (HR), cardiac output, and/or to 
elevation in minute ventilation (Åstrand, Rodahl, Dahl, 
& Strømme, 2003). A number of studies, which used 
different durations and levels of normobaric hypoxia, 
have focused on the autonomic nervous system (ANS) 
response using heart rate variability (HRV) assessment 
and have reported vagal activity withdrawal, and a rela-
tive increase in sympathetic activity (Al Haddad, Men-
dez-Villanueva, Bourdon, & Buchheit, 2012; Narkiewicz 
et al., 2006; Wille et al., 2012). The spectral analysis 
(SA) of HRV is a non-invasive tool to determine changes 
in autonomic cardiac activity (Akselrod et al., 1981). 
High frequency power (HF), reflects the influence of 
Introduction
In general, a reduction in the inspired oxygen fraction 
(FiO
2
) induces a decline in oxygen saturation (SpO
2
) 
(Iwasaki et al., 2006; Pighin et al., 2012) and causes 
homeostatic impairment due to systemic hypoxia 
(Mizuno et al., 1990; Ventura et al., 2003). The acute 
response of the O2 transport system to hypoxia is medi-
ated through changes in autonomic cardiac regulation 
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Background: A reduction in the inspired oxygen fraction (FiO
2
) induces a decline in arterial oxygen saturation (SpO
2
) 
and changes of heart rate variability (HRV). It has been shown that SpO
2
 and HRV responses to similar levels of 
acute normobaric hypoxia are inter-individual variable. Variable response may be influenced by normoxia reached 
maximal oxygen uptake (VO
2
max) value. Objective: The primary aim was to assess HRV and the SpO
2
 response to 
hypoxia, and examine the association with normoxic VO
2
max. Methods: Supine HRV and SpO
2
 were monitored 
during normobaric hypoxia (FiO
2
 = 9.6%) for 10 minutes in 28 subjects, aged 23.7 ± 1.7 years. HRV was evaluated 
by using both spectral and time domain HRV analysis. Low frequency (LF, 0.05–0.15 Hz) and high frequency (HF, 
0.15–0.50 Hz) power together with square root of the mean of the squares of the successive differences (rMSSD) 
were calculated and transformed by natural logarithm (Ln). Based on the SpO
2
 in hypoxia, subjects were divided into 
Resistant (RG, SpO
2
 ≥ 70.9%, n = 14) and Sensitive (SG, SpO
2
 < 70.9%, n = 14) groups. Perceived hypoxia tolerance 
was self-scored on a 4-level scale. Results: VO
2
max was higher in SG (62.4 ± 7.2 ml ⋅ kg–1 ⋅ min–1) compared with 
RG (55.5 ± 7.1 ml ⋅ kg–1 ⋅ min–1, p = .017, d = 0.97). A significant relationship (r = –.45, p = .017) between hypoxic-
normoxic difference in SpO
2
 and normoxic VO
2
max level was found. Vagal activity (Ln rMSSD) was significantly 
decreased (SG: p < .001, d = 2.64; RG: p < .001, d = 1.22), while sympathetic activity (Ln LF/HF) was relatively 
increased (p < .001, d = –1.40) in only the SG during hypoxia. Conclusions: Results show that subjects with a higher 
aerobic capacity exhibited a greater decline in SpO
2
, accompanied by greater autonomic cardiac disturbances during 
hypoxia. The SpO
2
 reduction was associated with perceived hypoxia comfort/discomfort. The hypoxia discomfort 
state was accompanied by a greater withdrawal in cardiac vagal activity.
Keywords: simulated altitude, haemoglobin desaturation, heart rate variability, maximal oxygen uptake, acute moun-
tain sickness
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the vagal outflow and vagally related respiratory modu-
lation of the heart known as respiratory sinus arrhyth-
mia (RSA) (Task Force of the European Society of Car-
diology and the North American Society of Pacing and 
Electrophysiology, 1996; Yasuma & Hayano, 2004). 
Low frequency power (LF) is considered the domi-
nant indicator of sympathetic activity by Ursino and 
Magosso (2003) while other authors understand the LF 
to be an indicator of both sympathetic and vagal activity 
together with baroreceptors activity (Malik & Camm, 
1993; Malliani, Lombardi, & Pagani, 1994; Zygmunt & 
Stanczyk, 2010). In addition, LF/HF ratio reflects the 
sympathovagal balance (Malliani, Pagani, Lombardi, & 
Cerutti, 1991). HRV may be also evaluated via using a 
time domain analysis (Buchheit, 2014).
Some studies have revealed that a similar level of 
short-term acute normobaric hypoxia induces indi-
vidual differences in the magnitude of SpO2 response 
that consequently are related to variable changes in 
autonomic cardiac regulation (Bobyleva & Glazachev, 
2007; Botek, Krejčí, De Smet, Gába, & McKune, 
2015). Importantly, the SpO2 response to hypoxia at 
rest (Burtscher, Flatz, & Faulhaber, 2004) and the 
combination of rest and exercise (Karinen, Peltonen, 
Kähönen, & Tikkanen, 2010; Rathat, Richalet, Herry, & 
Larmignat, 1992) has been suggested by some authors 
to be a promising marker of susceptibility to acute 
mountain sickness (AMS) development, while others 
have reported opposite findings (Wille et al., 2012; 
O’Connor, Dubowitz, & Bickler, 2004). For example, 
subjects that manifested AMS symptoms exhibited both 
a greater decline in SpO2 in hypoxia and a higher maxi-
mal oxygen uptake (VO2max) compared with subjects 
who were free from AMS symptoms (Karinen et al., 
2010). Previous research also reported that VO2max 
may have a negative influence on the SpO2 response 
to simulated altitude (2500–4600 m) at rest (Woorons 
et al., 2007) but particularly during moderate exercise 
intensity. Considering the above mentioned findings, 
we propose that differences in normoxic VO2max may 
contribute to the individual variation in SpO2 during 
hypoxic exposure, and consequently in the autonomic 
cardiac response to acute normobaric hypoxia at rest. 
Therefore, the primary aim of this study was to assess 
the SpO2 response to hypoxia (FiO2 = 9.6%) and the 
concomitant changes in autonomic cardiac regulation 
during resting conditions. The secondary aim was to 
determine the relationship between changes in SpO2 
response to hypoxia in subjects with different cardiore-
spiratory performance, and further to assess, whether 
10 minutes of hypoxia may have an impact on subjec-
tive perceived discomfort in healthy male subjects.
Methods
Participants
The testing group consisted of 28 healthy, physically 
active, non-smoking, male volunteers (aged 23.7 ± 1.7 
years, weight 78.4 ± 7.9 kg, height 180.3 ± 7.2 cm). 
The study was approved by the Institutional Research 
Ethics Committee and conformed to the recommen-
dations from the Declaration of Helsinki. Written 
informed consent was obtained from each participant. 
Participants underwent preliminary medical screening 
to identify cardiovascular and pulmonary conditions 
that would exclude them from the study. The exclu-
sion criteria included pathological changes in cardiac 
rhythm, hypertension, smoking and acute respiratory 
disease. The volunteers were free of medical compli-
cations taking no medication or dietary supplements 
which could impact the results of the test. The subjects 
had not been exposed to hypoxic environments for at 
least the previous two years.
Maximal oxygen uptake determination
VO
2
max, as a global indicator of physical fitness, and 
maximum heart rate (HRmax), were measured in nor-
moxia during an incremental running test on the tread-
mill (Valiant Plus, Lode, Groningen, Netherlands). 
The protocol consisted of a four minute warm-up 
(2 minutes at 8 km ⋅ h–1, with 0% elevation and then two 
minutes at the same speed at 5% elevation) followed by 
an increase in speed to 10 km ⋅ h–1 at 5% elevation for 
1 minute. From this point, at each minute, the speed 
was increased by 1 km ⋅ h–1, keeping elevation the same, 
up to 16 km ⋅ h–1. Then the speed was maintained and 
only the elevation increased by 2.5% per minute until 
exhaustion. Ventilation and gas exchange were recorded 
continuously (breath by breath) with 30 second averag-
ing and analysed by Blue Cherry 1.2 software (Gerath-
erm Respiratory, Bad Kissingen, Germany). The crite-
ria for attaining VO
2
max was defined as reaching one 
of the following criteria: a) respiratory exchange ratio 
of  > 1.11 (Howley, Bassett, & Welch, 1995); b) VO
2
 
plateau (defined as no increase in VO
2 
in response to an 
increase in work rate; Midgley, McNaughton, Polman, 
& Marchant, 2007). VO
2
max was considered the high-
est VO
2
 value in the final 30 seconds of the test (Millet 
et al., 2003). HR response was measured continuously 
using WearLink chest strap (Polar, Kempele, Finland).
Hypoxic experiment
One week after VO
2
max determination (Figure 1), 
the hypoxic experiment was performed between 8:00 
and 11:00 a.m. in a laboratory under standardized 
conditions (temperature 22 to 24 °C, relative humid-
ity ≤ 60%). Acoustic and visual stimuli were also 
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Oxygen saturation measurement
SpO2 was measured continuously throughout the exper-
imental protocol using a Nonin Avant 4000 (Nonin 
Medical, Minneapolis, MN, USA) pulse oximeter set 
on the right index finger. The oximeter served as a data 
collection device as well as a safety measure to ensure 
subject safety during hypoxia. The change in SpO2 
between the Hypoxia phase and Preliminary phase was 
calculated as ΔSpO2 = SpO2 Hypoxia – SpO2 Preliminary.
Heart rate variability analysis
To determine the breathing frequency (BF), HR, and 
HRV variables, the ECG was recorded at a sampling 
frequency of 1000 Hz using DiANS PF8 diagnostic sys-
tem (Dimea Group, Olomouc, Czech Republic). The 
system includes a chest strap, unit for recording and 
transmitting of ECG data, and a receiver connected 
to a personal computer with the special software. The 
ECG record was examined, and all ectopic beats and 
any artefacts were manually removed. The BF was 
determined based on changes in amplitude of QRS 
complex caused by respiratory movements (Salinger et 
al., 2005). A set of 300 artefact-free RR intervals was 
obtained from each measurement phase (Preliminary, 
Hypoxia, and Recovery). A SA HRV method was used 
to assess the cardiac autonomic activity and was per-
formed using the Fast Fourier Transform (Task Force 
of the European Society of Cardiology and the North 
American Society of Pacing and Electrophysiology, 
1996). Spectral powers were calculated in the bands as 
follows: LF from 0.05 to 0.15 Hz and HF from 0.15 to 
0.50 Hz. Additionally, LF/HF ratio and a time domain 
variable, the square root of the mean of the squares of 
the successive differences (rMSSD) was calculated.
From a methodological perspective, the influence 
of breathing patterns and tidal volume on the HRV 
components is well described (Brown, Beightol, Koh, 
& Eckberg, 1993; Hirsch & Bishop, 1981) where a 
decrease in BF and increased tidal volume cause an 
increase in the HF component. However, a BF < 9 
controlled to reduce their effects on HRV (Hori et al., 
2005). Subjects were required to avoid eating, drink-
ing coffee, tea and/or any substance affecting the ANS 
activity for at least two hours before the hypoxic experi-
ment. In addition, they were asked to avoid vigorous 
physical activity and alcohol for 48 hours before the 
hypoxic experiment.
The hypoxic experiment proceeded as follows (Fig-
ure 1): the subjects first breathed ambient air without a 
breathing mask. Each subject lay supine for 6 minutes 
to skip the transitory phase and to be able to assume 
stationarity of the data (Task Force of the European 
Society of Cardiology and the North American Soci-
ety of Pacing and Electrophysiology, 1996). After this 
standardization pause, SpO2 and electrocardiogram 
(ECG) data was recorded for 6 minutes and was 
used for calculation of “Preliminary phase” variables. 
When the preliminary recording was done, a research 
assistant fitted a face mask and the subject started to 
breathe air with a reduced O2 concentration. The first 
5 minutes of hypoxia served as a standardization pause 
and last 5 minutes was used for recording and calcula-
tion of “Hypoxia phase” variables. When 10 minutes of 
hypoxia elapsed, the mask was removed and the subject 
again breathed ambient air. One minute was skipped 
as standardization pause (Buchheit et al., 2004) and 
6 minute data recording followed. This data was used 
for calculation of “Recovery phase” variables.
The altitude of the laboratory was 260 m above 
sea level. The normobaric hypoxic environment 
(FiO2 = 9.6%, simulated altitude of 6 200 m) was cre-
ated using the MAG-10 system (Higher Peak, Boston, 
MA, USA). The given normobaric hypoxia level has 
been widely used in previous studies for intermittent 
hypoxia exposure (Millet, Roels, Schmitt, Woorons, & 
Richalet, 2010), and/or to determine effect of intermit-
tent hypoxia training to autonomic cardiac regulation 
(Bobyleva & Glazachev, 2007).
Figure 1. Course of hypoxic experimental protocol. Grey coloured phases were intended for SpO
2
 and 
ECG recording. Pauses were used to skip the transitory phase and to be able to assume stationarity of 
the data.
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breaths per minute may lead to an artificial increase in 
the LF with concomitant changes in the LF/HF ratio 
due to an RSA peak shift from HF into the LF. This 
could be a limitation in terms of interpreting both the 
vagal and the sympathetic contribution to the sinoatrial 
node activity (Sasaki & Maruyama, 2014; Vlčková et 
al., 2005). To avoid the potential methodological issue 
of BF, HRV is frequently measured under paced breath-
ing conditions (Botek et al., 2015; Roche et al., 2002). 
However, it has been reported that paced breathing 
may increase sympathetic activity (Patwardhan, Val-
lurupalli, Evans, Bruce, & Knapp, 1995). Therefore, 
in the present study we used spontaneous breathing 
throughout the experimental protocol. In this context, 
Penttilä et al. (2001) demonstrated that when sponta-
neous breathing is employed whilst measuring HRV, 
the time domain variable, rMSSD, is more resistant to 
altered BF and therefore seems to be a more accurate 
index of vagal activity than HF.
Subjective rating of comfort/discomfort during hypoxia
In order to examine the subjective score of well-being 
during hypoxia, we created a 4-level scale, adapted from 
Roach et al. (2000). Immediately before the end of the 
10 minutes of hypoxia, the subjects were asked to score 
their hypoxia subjective state on a 4-level scale. If the 
subjects experienced nausea or vomiting, headache, 
weakness during hypoxia, exposure to the hypoxia was 
stopped prematurely and this condition would be scored 
as a 0 level (severe incapacitating discomfort). None of 
the subjects experienced this level in the study. Level 1 
represented moderate discomfort, level 2 mild discom-
fort, and level 3 no discomfort. Based on these subjective 
scores the subjects were divided into two groups: hypoxia 
discomfort group (HDG, ratings 1 and 2, n = 14,) and 
hypoxia comfort group (HCG, rating 3, n = 14).
Statistical analysis
All data were checked for normality using the Kol-
mogorov-Smirnov test and are expressed as the mean ± 
standard deviation. Skewed probability distributions of 
LF, HF, LF/HF, and rMSSD variables were corrected 
applying a natural logarithm (Ln). According to previ-
ously published studies (Bobyleva & Glazachev, 2007; 
Botek et al., 2015) subjects were divided into two groups 
based on the median SpO2 value during the hypoxic 
phase (70.9%). The subjects with SpO2 ≥ 70.9% were 
assigned to the Resistant group (RG, range 70.9–86.7%, 
n = 14). The subjects with SpO2 < 70.9% were assigned 
to the Sensitive group (SG, range 58.4–70.9%, n = 14). 
A two-way analysis of variance (ANOVA) for repeated 
measures was used to evaluate the effect of hypoxia on 
selected variables. When the ANOVA revealed a sig-
nificant effect, multiple comparisons via the Fisher’s 
LSD post-hoc test were performed. A two-sample t-test 
was used to evaluate differences in selected variables 
between groups (SG vs RG, and HDG vs HCG). For 
all tests, statistical significance was set at α < 0.05.
Effect size was calculated as standardized mean dif-
ference according the formula (Fritz, Morris, & 
Richler, 2012) d = (m1 – m2)/SDp where m1 and m2 
are means to compare. Pooled standard deviation was 
calculated as follows (Fritz et al., 2012) 
 
where n
RG
, n
SG
 are sample 
sizes and SDRG, SDSG are standard deviations of RG, 
SG, respectively. When performing multiple compari-
sons (Figure 2), SD
RG
 and SD
SG
 were taken from Pre-
liminary phase only as recommended by (Morris & 
DeShon, 2002) because SD of Hypoxia and Recovery 
phases can be influenced by hypoxia exposure. Because 
SD
p
 = 1.1% calculated for SpO
2
 was below the accuracy 
of oximeter sensor expressed as SD = 2% (Nonin Avant 
4000 datasheet), we set SD
p
 = 2% for calculating effect 
size of SpO
2
 changes. The following threshold values 
for effect size were adopted (Hopkins, Marshall, Bat-
terham, & Hanin, 2009): < 0.2 (trivial), ≥ 0.2 (small), 
≥ 0.6 (moderate), ≥ 1.2 (large), ≥ 2.0 (very large), ≥ 4.0 
(extremely large).
The Pearson’s correlation coefficient (r) was cal-
culated to assess the relationships between ΔSpO
2
 and 
different variables. The magnitude of r was interpreted 
according following thresholds (Hopkins et al., 2009): 
< 0.1 (trivial), ≥ 0.1 (small), ≥ 0.3 (moderate), ≥ 0.5 
(large), ≥ 0.7 (very large), and ≥ 0.9 (extremely large). 
Statistical analysis was performed using STATISTICA 
12.0 (StatSoft, Tulsa, OK, USA) and MATLAB 8.4 
(MathWorks, Natick, MA, USA).
Results
Means and standard deviations of SpO
2
, HR, HRV 
variables, and BF during Preliminary, Hypoxia, and 
Recovery phases are provided in Table 1. Statistical sig-
nificances and effect sizes of changes between phases 
and also between RG and SG are depicted in Figure 2.
Correlation analyses (Figure 3) showed significant 
associations between ΔSpO
2 
and ΔLn HF (r = .54, large 
effect, p = .003) and between ΔSpO
2 
and ΔLn rMSSD 
(r = .64, large effect, p < .001). A significant relation-
ship was also found for changes in ΔSpO
2
 and VO
2
max 
(r = –.45, moderate effect, p = .017). In addition, the 
mean VO
2
max values were significantly (p = .017, 
d = 0.97, moderate effect, two-sample t-test) greater 
in SG (62.4 ± 7.2 ml ⋅ kg–1 ⋅ min–1) compared with RG 
(55.5 ± 7.1 ml ⋅ kg–1 ⋅ min–1). Upon examination of the 
changes between the hypoxia and the preliminary 
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Figure 2. Changes in the oxygen saturation (a), heart rate (b), natural logarithm of low fre-
quency power (c), natural logarithm of high-frequency power (d), natural logarithm of square 
root of the mean of the squares of the successive differences (e), natural logarithm of low-fre-
quency/high-frequency ratio (f) and breath frequency (g) during Preliminary, Hypoxia, and Re-
covery phases. Values are presented as the mean ± standard deviation. Comparisons by means 
of Fisher’s LSD post-hoc test are presented. RG = resistant group (saturation during hypoxia 
≥ 70.9%, n = 14); SG = sensitive group (saturation during hypoxia < 70.9%, n = 14); * = p < .05; 
+ = .05 ≤ p < .06; ns = nonsignificant; tr = trivial effect size (|d| < 0.2); sm = small effect size 
(|d| ≥ 0.2); mo = moderate effect size (|d| ≥ 0.6); la = large effect size (|d| ≥ 1.2); vl = very 
large effect size (|d| ≥ 2.0); el = extremely large effect size (|d| ≥ 4.0).
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phases (Figure 4), there were significant (p = .017, 
d = 0.97, moderate effect, two-sample t-test) differences 
in ΔLn LF/HF between HDG (1.7 ± 1.5) and HCG 
(0.5 ± 0.9). There was also a significant difference 
(p = .027, d = –0.88, moderate effect, two-sample t-test) 
in ΔSpO2 between HDG (–28.2 ± 7.3%) and HCG 
(–21.9 ± 6.8%). However, there was insignificant differ-
ence (p = .366, d = 0.35, small effect, two-sample t-test) 
in VO2max between HDG (60.3 ± 7.6 ml ⋅ kg
–1 ⋅ min–1) 
and HCG (57.6 ± 8.1 ml ⋅ kg–1 ⋅ min–1).
Discussion
This study was primarily designed to assess SpO
2
 and 
autonomic cardiac regulation responses to short-term 
exposure to normobaric hypoxia (FiO2= 9.6%), and 
consequently to verify, whether normoxic VO2max 
level may be related to the SpO2 response to hypoxia 
under resting conditions. In relation to the SpO2 and 
HRV response to hypoxia, we also tested, whether 
10 minutes of hypoxia have an impact of subjective rat-
ings of perceived comfort/discomfort.
The main findings of the study were a) during 
hypoxia, SG showed a greater decline in vagal activity 
compared with RG, with a relative increase in sym-
pathetic activity apparent in SG only; b) there was a 
negative correlation (r = –.45, p = .017) between nor-
moxic VO2max level and ΔSpO2 in hypoxia; c) HDG 
demonstrated a greater reduction in SpO2 with a rela-
tive increase in sympathetic activity in hypoxia com-
pared with HCG; d) Ln rMSSD exhibited a stronger 
association (r = .64; p < .001) with SpO2 during hypoxia 
compared with Ln HF (r = .54; p = .003).
Our results demonstrated that SpO2 was reduced 
during hypoxia in both RG and SG, with the decrease 
in SpO2 level significantly greater in SG, where SG 
demonstrated a significantly greater VO2max compared 
with RG. In addition, a correlation (r = –.45, p = .017) 
was found between normoxic VO2max and the SpO2 
response during acute exposure to normobaric hypoxia 
at rest. From this finding, it appears that individuals 
with greater cardiorespiratory fitness may be more sen-
sitive to an acute reduction in oxygen delivery to tissues 
at rest compared with individuals who have a lower 
VO2max. Based on this result, one would hypothesize 
that VO2max level may be considered as an indicator 
(predictor) of SpO2 response to hypoxia exposure in 
previously non-acclimatized subjects.
Our findings are supported by Woorons et al. 
(2007) who reported that both greater arterial 
desaturation and lower end-tidal oxygen pressure was 
found in endurance trained compared with untrained 
subjects during 5 minutes rest, and following moder-
ate exercise, while subjects experienced normobaric 
hypoxia (FiO2 = 15.4 to 11.7%). These authors sug-
gested that a decline in arterial desaturation at rest, but 
particularly during moderate exercise, due to a blunted 
chemoreceptor sensitivity to hypoxia, resulting in an 
insufficient ventilatory response (a relative hypoventi-
lation) to severe hypoxia in trained subjects. Botek et 
al. (2015) investigated the SpO2 and HRV response to 
normobaric hypoxia in health males, and observed a 
return of SpO2 to pre-hypoxia level within 5 minutes 
Table 1  
Means and SDs of SpO
2
, HR, HRV variables, and BF during Preliminary, Hypoxia, and Recovery phases
Variable
Preliminary Hypoxia Recovery
RG SG RG SG RG SG
SpO2 (%) 96.6 ± 1.3 97.1 ± 1.0 77.5 ± 5.5 66.2 ± 4.1 94.7 ± 2.4 93.7 ± 2.9
HR (beats/min) 62.5 ± 8.7 60.0 ± 9.3 76.7 ± 11.7 82.2 ± 9.7 59.4 ± 8.4 57.2 ± 8.2
LF (ms2) 1397 ± 2345 899 ± 896 1039 ± 1641 982 ± 1676 1205 ± 941 1076 ± 1104
HF (ms2) 1404 ± 1235 1689 ± 1292 1095 ± 1497 428 ± 1005 1498 ± 1674 1573 ± 1537
rMSSD (ms) 58.8 ± 27.5 71.5 ± 35.2 40.2 ± 34.0 24.8 ± 31.0 60.3 ± 35.0 63.1 ± 34.2
LF/HF 1.7 ± 2.7 0.8 ± 0.7 2.3 ± 2.8 4.6 ± 6.9 1.8 ± 2.3 1.1 ± 1.1
Ln LF (ms2) 6.5 ± 1.2 6.4 ± 0.9 6.0 ± 1.3 5.8 ± 1.6 6.7 ± 1.0 6.6 ± 0.8
Ln HF (ms2) 6.9 ± 1.0 7.2 ± 0.8 5.9 ± 1.7 4.8 ± 1.4 6.8 ± 1.1 6.9 ± 1.0
Ln rMSSD (ms) 4.0 ± 0.5 4.1 ± 0.5 3.4 ± 0.9 2.8 ± 0.8 4.0 ± 0.5 4.0 ± 0.6
Ln LF/HF –0.4 ± 1.3 –0.7 ± 1.1 0.1 ± 1.3 0.9 ± 1.1 0.0 ± 1,2 -0.3 ± 1.0
BF 11.1 ± 3.4 11.0 ± 2.0 10.8 ± 2.6 11.5 ± 2.0 9.5 ± 2.4 10.1 ± 1.4
Note. RG = resistant group (saturation during hypoxia ≥ 70.9%, n = 14); SG = sensitive group (saturation during hypoxia < 70.9%, 
n = 14); SpO2 = arterial oxygen saturation; HR =  heart rate; LF = low-frequency power; HF = high-frequency power; rMSSD = square 
root of the mean of the squares of the successive differences; LF/HF = low-frequency/high-frequency ratio; Ln = natural logarithm; 
BF = breathing frequency.
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of recovery with no differences between SG and RG 
groups using paced breathing at 12 breaths per minute. 
Similarly, our results showed no differences between 
groups, while SpO
2
 in SG was delayed in returning 
to the baseline level when BF was at 10 breaths per 
minute. Thus, it seems that a lower BF in the present 
study may have possibly contributed to the incomplete 
recover of SpO
2
 after hypoxia exposure.
Regarding HRV, we found insignificant and small 
changes in the sympathovagal balance (LF/HF ratio) 
across the three experimental phases in RG. Similar 
results for LF/HF were published previously (Bobyleva 
& Glazachev, 2007; Botek et al., 2015). A significant 
reduction in vagal activity (Ln HF) occurred during the 
hypoxia period compared with the preliminary phase in 
both RG (moderate effect) and SG (very large effect). 
However, SG demonstrated a significantly (large effect) 
greater withdrawal in vagal activity compared with 
RG. The different vagal activity responses to hypoxia 
between groups resulted in greater shift in sympa-
thovagal balance towards sympathetic side in the SG 
compared with RG. The difference in sympathovagal 
balance (Ln LF/HF) during hypoxia between SG and 
RG was moderate but only approaching significance 
(p = .052). Based on this result, it is tenable that dif-
ferences in autonomic cardiac disturbances during 
acute normobaric hypoxia could be partly attributed 
to VO
2
max level. Bobyleva and Glazachev (2007) dem-
onstrated that hypoxia-sensitive subjects undergoing 
intermittent hypoxic training (IHT) (20 sessions of 
60 minutes) had a blunted sympathetic response and 
a slower decline in SpO
2
 during hypoxia. Therefore, 
future research is needed to clarify the effect of IHT on 
SpO
2
 and ANS response in aerobic well trained subjects 
that in our study exhibit both autonomic cardiac impair-
ment and a greater SpO
2 
change during acute hypoxia.
During the hypoxic phase, Ln rMSSD, as a time 
domain index of vagal activity (Buchheit, 2014), was 
significantly and at least largely reduced compared 
with the preliminary phase in both groups. Moreover, 
Figure 3. Correlation analysis between oxygen desatu-
ration (ΔSpO
2
 = SpO
2 Hypoxia
 – SpO
2 Preliminary
) and the 
VO
2
max value (a), the change in the natural logarithm 
of square root of the mean of the squares of the succes-
sive differences (b, ΔLn rMSSD = Ln rMSSD
Hypoxia
 – Ln 
rMSSD
Preliminary
), and the change in the natural logarithm 
of high-frequency power (c, ΔLn HF = Ln HF
Hypoxia
 – Ln 
HF
Preliminary
). Circle mark = resistant group (saturation 
during hypoxia ≥ 70.9%, n = 14); triangle mark = sensi-
tive group (saturation during hypoxia < 70.9%, n = 14). 
Dashed lines denote 0.95-confidence interval.
Figure 4. Differences in the oxygen desaturation (a, 
ΔSpO
2
 = SpO
2
 
Hypoxia
 – SpO
2
 
Preliminary
) and natural loga-
rithm of low-frequency/high-frequency ratio change (b, 
ΔLn LF/HF = Ln LF/HF
Hypoxia
 – Ln LF/HF
Preliminary
) 
between hypoxia comfort group (HCG, n = 14) and 
hypoxia discomfort group (HDG, n  14). Values are 
presented as the mean ± standard deviation. The com-
parison by means of two-sample t-test is presented.
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Ln rMSSD (r = .64, p < .001) was closely related to 
the SpO2 level during hypoxia compared with Ln HF 
power (r = .54, p = .003). A possible reason for this 
finding may be because of six subjects whose BF was 
under 9 breaths per minute during the hypoxic phase. 
The result of this was previously described (García-
González, Vázquez-Seisdedos, & Pallàs-Areny, 2000; 
Vlčková et al., 2005) by an artificial increase in both 
LF and LF/HF ratio due to RSA peak shift towards 
the LF. Based on these results, it seems that rMSSD 
is a more robust index of vagal activity in normobaric 
hypoxia than HF when using spontaneous breathing.
There is an increasing number of travellers who 
journey to high altitudes (> 2400 m), where there 
is increased risk of AMS development (Gallagher & 
Hackett, 2004). It has previously been shown that both 
reduced SpO2 (Burtscher et al., 2004; Karinen et al., 
2010) and a stimulated sympathetic system (Mazzeo 
et al., 1995) during hypoxia contributes to AMS sus-
ceptibility. Our findings demonstrate a significantly 
greater desaturation level in subjects who rated their 
10 minute hypoxia experience as mild or moderately 
uncomfortable, because of the presence of nausea or 
vomiting, headache, and weakness, while subjects free 
of perceived hypoxia-induced side effects demonstrated 
a significantly lower desaturation together with a lower 
relative increase in sympathetic activity. In a previous 
study it was reported that measurement of the SpO2 
responses to hypoxia (FiO2 = 11.5%) at rest and during 
5 minute exercise (50% of normoxic VO2max) allows 
the detection of those subjects who are more liable 
to suffer from AMS (Rathat et al., 1992). It was also 
suggested that the monitoring of the SpO2 response to 
hypobaric or normobaric hypoxia represents a useful 
method for detecting subjects who are highly suscep-
tible to AMS (Burtscher et al., 2004). However, in 
contrast, Rathat et al. (1992) reported that subjects 
should be exposed to hypoxia in resting state of at least 
20–30 minutes to identify risk of AMS. Based on the 
previous literature (Burtscher et al., 2004; Rathat et 
al., 1992) and our findings, we feel that a controlled 
exposure to simulated altitude equal to ~6200 m for 
10 minutes in unacclimatized persons before the travel-
ling to high altitude may serve as the screening mea-
surement to assess an individual’s hypoxia tolerance. 
Susceptibility to AMS was, in addition to a reduction 
in SpO2, also associated with better aerobic capacity, 
younger age, and higher body mass index in mountain 
climbers (Karinen et al., 2010). However, we did not 
find a significant difference in VO2max between HCG 
and HDG in contrast to Karinen et al. (2010). A dis-
crepancy in results may be explained by the difference 
in study design. In our study, volunteers were exposed 
to normobaric hypoxia for 10 minutes during rest, 
whereas Karinen et al. (2010) assessed SpO2 response 
in climbers during mountain expeditions.
A limitation of this study was that subjects wore a 
face mask, and therefore, it was not possible to assess 
changes in the ventilatory response that may have 
occurred during the phases of the study. Therefore, 
the HRV diagnostics system (DiANS PF8) was used 
to evaluate the changes in BF. Future research should 
include ventilatory response monitoring and the con-
tinual monitoring of blood pressure that may be benefi-
cial for providing a more complex view of the transport 
system response during acute hypoxia.
Conclusion
The results demonstrated that a SpO
2
 reduction 
increases perceived hypoxia discomfort, which is 
accompanied by a greater withdrawal in cardiac vagal 
activity. In addition, it was shown that 10 minutes 
of hypoxia exposure induced a greater reduction in 
SpO2 and autonomic cardiac disturbance in individu-
als with greater normoxic VO2max values. A practical 
application of this finding is that hypoxic exposure 
before travel to altitude may help with the screening 
of hypoxia-sensitive persons who may be more prone 
to suffer AMS, specifically in individuals with a high 
aerobic capacity.
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